Global Paediatric Vaccine Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Aug 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Paediatric  Vaccine Market By Vaccine Type (Monovalent and Multivalent), Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate and Other Technologies), Application (Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR)​ and Other Applications), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

 Paediatric Vaccine MarketMarket Analysis and Insights of Paediatric Vaccine Market

Data Bridge Market Research analyses that the paediatric  vaccine will exhibit a CAGR of around 9.30% for the forecast period of 2021-2028. Rising unmet needs for chronic diseases, surge in the research and development activities for the development of novel drugs and therapies and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of paediatric vaccine market.

Vaccines are produced with the components containing small amounts of illness germs that are effective against illness. Each vaccine includes an amount of germs where the germs are either deceased or strengthened. This means that the vaccines do not trigger the disease rather act as an agent killing it. Vaccines strengthen the immune system which in turn acts as a shield against the germs.

Growing awareness in regards to the security against the burden of chronic diseases worldwide is a major factor fostering the growth of the paediatric  vaccine market. Rising expenditure on the development of healthcare infrastructure and upsurge in the demand for novel therapies and treatment are other factors also fostering the growth of the paediatric  vaccine market. Strategic collaboration and licensing deal among the major players for the development of therapeutics, boost in the funding by the government for life science projects and personal disposable income are some other indirect determinants that will create lucrative paediatric  vaccine market growth opportunities.

However, non-favourable reimbursement scenario in the developing and under developed economies will pose a major challenge to the paediatric  vaccine market growth. High costs associated with immunization will further challenge the paediatric  vaccine market growth rate. Absence of information and lack of medical expertise in the underdeveloped economies coupled with less access to healthcare in low- and middle-income countries will further derail the paediatric  vaccine market growth rate.

This paediatric  vaccine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on paediatric  vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Paediatric  Vaccine Market Scope and Market Size

The paediatric  vaccine market is segmented on the basis of vaccine type, technology and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of vaccine type, the paediatric  vaccine market is segmented into monovalent and multivalent.
  • On the basis of technology, the paediatric  vaccine market is segmented into live attenuated, inactivated, subunit, toxoid, conjugate and other technologies.
  • On the basis of application, the paediatric  vaccine market is segmented into infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR) and other applications.

Paediatric  Vaccine Market Country Level Analysis

The paediatric  vaccine market is analysed and market size insights and trends are provided by country, vaccine type, technology and application as referenced above.

The countries covered in the paediatric  vaccine market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the paediatric  vaccine market owing to the rising expenditure for the development of novel therapies and favourable reimbursement scenario in this region. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure and increasing prevalence of chronic disorders.

The country section of the paediatric  vaccine market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The paediatric  vaccine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Paediatric Vaccine Market Share Analysis

The paediatric  vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to paediatric  vaccine market.

The major players covered in the paediatric  vaccine market report are Incyte., SINOVAC, DAIICHI SANKYO COMPANY, LIMITED., Astellas Pharma Inc., Novo Nordisk A/S, Grifols, S.A., Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., Astrazeneca, Bristol-Myers Squibb Company, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Novartis AG,  Eli Lilly and Company, Abbott, Merck & Co., Inc. and Lupin Pharmaceuticals, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Paediatric Vaccine Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions